ALEXANDRIA, Va., July 30 -- United States Patent no. 12,371,419, issued on July 29, was assigned to Step Pharma S.A.S. (Paris).
"Aminopyrimidine/pyrazine derivatives as CTPS1 inhibitors" was invented by Abdul Quddus (Nottingham, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "Compounds of formula (I), and related aspects."
The patent was filed on April 16, 2024, under Application No. 18/636,731.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=12371419&OS=12371419&RS=12371419
Disclaimer: Curated by HT Syndication....